MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$90,625K
EPS
-$0.59
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
68,607
General and administrative
24,724
Total operating expenses
93,331
Loss from operations
-93,331
Interest income
2,682
Other income, net
52
Total other income, net
2,734
Net loss before income tax expense
-90,597
Net loss
-90,597
Net unrealized (loss) gain on marketable securities
-28
Comprehensive loss
-90,625
Basic EPS
-0.59
Diluted EPS
-0.59
Basic Average Shares
152,971,259
Diluted Average Shares
152,971,259
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$90,625K Net loss-$90,597K Net unrealized(loss) gain on...-$28K Interest income$2,682K Other income, net$52K Net loss beforeincome tax expense-$90,597K Total other income,net$2,734K Loss from operations-$93,331K Total operatingexpenses$93,331K Research and development$68,607K General andadministrative$24,724K

Tenaya Therapeutics, Inc. (TNYA)

Tenaya Therapeutics, Inc. (TNYA)